AFANAT 40MG

Afanat 40mg Tablet is an anticancer medication that contains Afatinib dimaleate as its active component. It is prescribed for patients diagnosed with non-small cell lung cancer (NSCLC) whose tumors exhibit specific (non-resistant) abnormal epidermal growth factor receptor (EGFR) genes, as well as for those with metastatic squamous NSCLC that has progressed following platinum-based chemotherapy.

Cancer is characterized by the abnormal and uncontrolled proliferation of cells. Before starting this medication, consult your doctor if you have any kidney issues, respiratory problems, liver conditions, heart ailments, sugar intolerance, severe dry eye, or other ocular concerns.

Afanat 40mg Tablet has the potential to slow down disease progression and enhance overall survival rates, while also assisting patients in achieving a better quality of life over an extended period. This includes improvements in physical capabilities, pain reduction, and enhanced mental and emotional well-being. Inform your doctor if you wear contact lenses or are breastfeeding prior to using this medication. Additionally, limit your sun exposure, as this drug may increase your skin’s sensitivity to sunlight. It is not advised for use in children and adolescents under 18 years of age. Do not discontinue this medication without first consulting your healthcare provider.